Emcure Pharmaceuticals Past Earnings Performance
Past criteria checks 2/6
Emcure Pharmaceuticals has been growing earnings at an average annual rate of 17.1%, while the Pharmaceuticals industry saw earnings growing at 17% annually. Revenues have been growing at an average rate of 6.8% per year. Emcure Pharmaceuticals's return on equity is 16.9%, and it has net margins of 7.5%.
Key information
17.1%
Earnings growth rate
17.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 6.8% |
| Return on equity | 16.9% |
| Net Margin | 7.5% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Emcure Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 66,583 | 4,982 | 16,166 | 0 |
| 31 Dec 23 | 65,361 | 5,493 | 15,300 | 0 |
| 30 Sep 23 | 64,139 | 6,003 | 14,434 | 0 |
| 30 Jun 23 | 61,998 | 5,662 | 13,848 | 0 |
| 31 Mar 23 | 59,858 | 5,320 | 13,261 | 0 |
| 31 Mar 22 | 58,554 | 6,622 | 11,825 | 0 |
| 31 Mar 21 | 50,335 | 5,808 | 10,297 | 0 |
| 31 Mar 20 | 50,486 | 836 | 12,995 | 0 |
| 31 Mar 19 | 47,172 | 1,893 | 12,092 | 0 |
Quality Earnings: 544210 has high quality earnings.
Growing Profit Margin: 544210's current net profit margins (7.5%) are lower than last year (8.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 544210's earnings have grown by 17.1% per year over the past 5 years.
Accelerating Growth: 544210's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 544210 had negative earnings growth (-6.4%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (18%).
Return on Equity
High ROE: 544210's Return on Equity (16.9%) is considered low.